Woolas R - Search Results

1

The cost-effectiveness of screening for ovarian cancer: results from the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).

Menon U, McGuire AJ, Raikou M, Ryan A, Davies SK, Burnell M, Gentry-Maharaj A, Kalsi JK, Singh N, Amso NN, Cruickshank D, Dobbs S, Godfrey K, Herod J, Leeson S, Mould T, Murdoch J, Oram D, Scott I, Seif MW, Williamson K, Woolas R, Fallowfield L, Campbell S, Skates SJ, Parmar M, Jacobs IJ. Menon U, et al. Among authors: woolas r. Br J Cancer. 2017 Aug 22;117(5):619-627. doi: 10.1038/bjc.2017.222. Epub 2017 Jul 25. Br J Cancer. 2017. PMID: 28742794 Free PMC article.

2

Raised serum CA 125 preceding the diagnosis of carcinoma of the fallopian tube: two case reports.

Davies AP, Fish A, Woolas R, Oram D. Davies AP, et al. Among authors: woolas r. Br J Obstet Gynaecol. 1991 Jun;98(6):602-3. doi: 10.1111/j.1471-0528.1991.tb10381.x. Br J Obstet Gynaecol. 1991. PMID: 1873255 No abstract available.

3

Immunocytochemical and serological expression of CA 125: a clinicopathological study of 40 malignant ovarian epithelial tumours.

Leake J, Woolas RP, Daniel J, Oram DH, Brown CL. Leake J, et al. Among authors: woolas rp. Histopathology. 1994 Jan;24(1):57-64. doi: 10.1111/j.1365-2559.1994.tb01271.x. Histopathology. 1994. PMID: 8144143

4

Serum CA 125 in a pregnancy generated by ovum donation.

Norman-Taylor JQ, Woolas RP, Oram DH, Grudzinskas JG. Norman-Taylor JQ, et al. Among authors: woolas rp. Hum Reprod. 1994 Jan;9(1):147-8. doi: 10.1093/oxfordjournals.humrep.a138305. Hum Reprod. 1994. PMID: 8195339

5

The adnexal mass: benign or malignant? Evaluation of a risk of malignancy index.

Davies AP, Jacobs I, Woolas R, Fish A, Oram D. Davies AP, et al. Among authors: woolas r. Br J Obstet Gynaecol. 1993 Oct;100(10):927-31. doi: 10.1111/j.1471-0528.1993.tb15109.x. Br J Obstet Gynaecol. 1993. PMID: 8217976

6

Elevation of multiple serum markers in patients with stage I ovarian cancer.

Woolas RP, Xu FJ, Jacobs IJ, Yu YH, Daly L, Berchuck A, Soper JT, Clarke-Pearson DL, Oram DH, Bast RC Jr. Woolas RP, et al. J Natl Cancer Inst. 1993 Nov 3;85(21):1748-51. doi: 10.1093/jnci/85.21.1748. J Natl Cancer Inst. 1993. PMID: 8411259

7

Soluble interleukin-2 receptor alpha is elevated in sera of patients with benign ovarian neoplasms and epithelial ovarian cancer.

Hurteau JA, Woolas RP, Jacobs IJ, Oram DC, Kurman CC, Rubin LA, Nelson DL, Berchuck A, Bast RC Jr, Mills GB. Hurteau JA, et al. Among authors: woolas rp. Cancer. 1995 Nov 1;76(9):1615-20. doi: 10.1002/1097-0142(19951101)76:9<1615::aid-cncr2820760918>3.0.co;2-g. Cancer. 1995. PMID: 8635066 Clinical Trial.

8

Molecular approaches to prevention and detection of epithelial ovarian cancer.

Bast RC Jr, Boyer CM, Xu FJ, Wiener J, Dabel R, Woolas R, Jacobs I, Berchuck A. Bast RC Jr, et al. Among authors: woolas r. J Cell Biochem Suppl. 1995;23:219-22. doi: 10.1002/jcb.240590929. J Cell Biochem Suppl. 1995. PMID: 8747399 Review.

9

Risk of diagnosis of ovarian cancer after raised serum CA 125 concentration: a prospective cohort study.

Jacobs IJ, Skates S, Davies AP, Woolas RP, Jeyerajah A, Weidemann P, Sibley K, Oram DH. Jacobs IJ, et al. Among authors: woolas rp. BMJ. 1996 Nov 30;313(7069):1355-8. doi: 10.1136/bmj.313.7069.1355. BMJ. 1996. PMID: 8956699 Free PMC article. Clinical Trial.

10

Screening for ovarian cancer: a pilot randomised controlled trial.

Jacobs IJ, Skates SJ, MacDonald N, Menon U, Rosenthal AN, Davies AP, Woolas R, Jeyarajah AR, Sibley K, Lowe DG, Oram DH. Jacobs IJ, et al. Among authors: woolas r. Lancet. 1999 Apr 10;353(9160):1207-10. doi: 10.1016/S0140-6736(98)10261-1. Lancet. 1999. PMID: 10217079 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

61 results

Search Page